XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information |
| Three Months Ended September 30, |  | Nine Months Ended September 30,
In millions | 2022 |  | 2021 |  | 2022 |  | 2021
Net sales |  |  |  |  |  |  |
Performance Materials | $ | 144.9 |  |  | $ | 118.1 |  |  | $ | 415.7 |  |  | $ | 384.8 |
Performance Chemicals | 337.1 |  |  | 258.7 |  |  | 869.0 |  |  | 670.7 |
Total net sales (1) | $ | 482.0 |  |  | $ | 376.8 |  |  | $ | 1,284.7 |  |  | $ | 1,055.5 |
Segment EBITDA (2) |  |  |  |  |  |  |
Performance Materials | $ | 61.2 |  |  | $ | 56.4 |  |  | $ | 194.7 |  |  | $ | 191.4 |
Performance Chemicals | 77.0 |  |  | 63.1 |  |  | 183.6 |  |  | 151.2 |
Total Segment EBITDA (2) | $ | 138.2 |  |  | $ | 119.5 |  |  | $ | 378.3 |  |  | $ | 342.6 |
Interest expense, net | (11.5) |  |  | (11.6) |  |  | (37.3) |  |  | (36.2) |
(Provision) benefit for income taxes | (20.4) |  |  | 4.8 |  |  | (53.9) |  |  | (37.7) |
Depreciation and amortization - Performance Materials | (8.9) |  |  | (8.9) |  |  | (26.7) |  |  | (26.9) |
Depreciation and amortization - Performance Chemicals | (16.8) |  |  | (18.7) |  |  | (51.9) |  |  | (54.8) |
Restructuring and other income (charges), net (3) | (3.3) |  |  | (4.1) |  |  | (10.6) |  |  | (12.3) |
Acquisition and other-related costs (4) | (1.9) |  |  | (0.2) |  |  | (1.9) |  |  | (0.9) |
Litigation verdict charge (5) | — |  |  | (85.0) |  |  | — |  |  | (85.0) |
Net income (loss) | $ | 75.4 |  |  | $ | (4.2) |  |  | $ | 196.0 |  |  | $ | 88.8 |
_______________ (1) Relates to external customers only, all intersegment sales and related profit have been eliminated in consolidation. (2) Segment EBITDA is the primary measure used by our chief operating decision maker to evaluate the performance of and allocate resources among our operating segments. Segment EBITDA is defined as segment revenue less segment operating expenses (segment operating expenses consist of costs of sales, selling, general and administrative expenses, research and technical expenses, other (income) expense, net, excluding depreciation and amortization). We have excluded the following items from segment EBITDA: interest expense, net, associated with corporate debt facilities, income taxes, depreciation, amortization, restructuring and other (income) charges, net, acquisition and other related costs, litigation verdict charges, pension and postretirement settlement and curtailment (income) charges, net. (3) Income (charges) for all periods presented relate to restructuring activity and costs associated with the business transformation initiative. For the three and nine months ended September 30, 2022, charges of $1.1 million and $3.7 million relate to the Performance Materials segment and charges of $2.2 million and $6.9 million relate to the Performance Chemicals segment, respectively. For the three and nine months ended September 30, 2021, charges of $1.1 million and $4.5 million relate to the Performance Materials segment and charges of $3.0 million and $7.8 million relate to the Performance Chemicals segment, respectively. For more detail on the charges incurred see Note 12. (4) For the three and nine months ended September 30, 2022, all acquisition costs relate to the integration of the Ozark Materials business into our Performance Chemicals segment. For the three and nine months ended September 30, 2021, charges of zero and $0.2 million relate to the acquisition of a strategic investment in the Performance Materials segment and charges of $0.2 million and $0.7 million relate to the integration of the Perstorp Capa business into our Performance Chemicals segment, respectively. (5) For the three and nine months ended September 30, 2021, litigation verdict charge relates to the Performance Materials segment. Refer to Note 14 for additional information.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration